Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
6,753 JPY | +2.71% | -0.16% | -4.24% |
May. 24 | BioArctic, Eisai's Azlheimer’s Disease Drug Wins Regulatory Nod in South Korea | MT |
May. 16 | Eisai's Attributable Profit Falls 23.5% in Fiscal 2024 | MT |
Sales 2024 | 742B 4.71B | Sales 2025 * | 768B 4.88B | Capitalization | 1,937B 12.31B |
---|---|---|---|---|---|
Net income 2024 | 42.41B 269M | Net income 2025 * | 49.61B 315M | EV / Sales 2024 | 2.21 x |
Net cash position 2024 | 145B 923M | Net cash position 2025 * | 223B 1.42B | EV / Sales 2025 * | 2.23 x |
P/E ratio 2024 |
42
x | P/E ratio 2025 * |
38.7
x | Employees | 11,076 |
Yield 2024 |
2.57% | Yield 2025 * |
2.39% | Free-Float | 93.84% |
Latest transcript on Eisai Co., Ltd.
1 day | +2.71% | ||
1 week | -0.16% | ||
1 month | +3.11% | ||
3 months | +8.73% | ||
6 months | -12.41% | ||
Current year | -4.24% |
Managers | Title | Age | Since |
---|---|---|---|
Haruo Naito
CEO | Chief Executive Officer | 76 | 75-09-30 |
Mitsuru Shomon
DFI | Director of Finance/CFO | - | - |
Makoto Hoketsu
CTO | Chief Tech/Sci/R&D Officer | - | - |
Members of the board | Title | Age | Since |
---|---|---|---|
Haruo Naito
CEO | Chief Executive Officer | 76 | 75-09-30 |
Fumihiko Ike
BRD | Director/Board Member | 72 | 21-05-31 |
Toru Moriyama
BRD | Director/Board Member | 69 | - |
Name | Weight | AuM | 1st Jan change | Investor Rating |
---|---|---|---|---|
5.78% | 19 M€ | +11.22% | ||
1.23% | 240 M€ | +17.47% | ||
1.13% | 28,258 M€ | +15.99% | - |
Date | Price | Change | Volume |
---|---|---|---|
24-05-31 | 6,753 | +2.71% | 1,967,300 |
24-05-30 | 6,575 | -1.37% | 1,299,700 |
24-05-29 | 6,666 | -1.02% | 879,300 |
24-05-28 | 6,735 | -0.68% | 860,300 |
24-05-27 | 6,781 | +0.25% | 875,500 |
Delayed Quote Japan Exchange, May 31, 2024 at 02:00 am EDT
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-4.24% | 12.32B | |
+40.73% | 739B | |
+32.83% | 598B | |
-6.30% | 353B | |
+15.15% | 318B | |
+4.05% | 285B | |
+15.00% | 240B | |
-5.52% | 206B | |
+6.17% | 164B | |
-0.45% | 162B |
- Stock Market
- Equities
- 4523 Stock